| Literature DB >> 36189244 |
Bin Sun1,2, Boguang Sun1,3, Beibei Zhang1,4, Li Sun1,3,5.
Abstract
Water temperature elevation as a consequence of global warming results in increased incidence of bacterial disease, such as edwardsiellosis, in fish farming. Edwardsiellosis is caused by the bacterial pathogen Edwardsiella tarda and affects many farmed fish including flounder (Paralichthys olivaceus). Currently, the effect of temperature on the metabolic response of flounder to E. tarda infection is unclear. In this study, we found that compared to low temperature (15°C), high temperature (23°C) enhanced E. tarda dissemination in flounder tissues. To examine the impact of temperature on the metabolism of flounder induced by E. tarda, comparative metabolomics were performed, which identified a large number of metabolites responsive to E. tarda invasion and temperature alteration. During E. tarda infection, the metabolic profile induced by elevated temperature was mainly featured by extensively decreased amino acids and TCA intermediates such as succinate, a proven immune regulator. Further, 38 potential metabolite markers of temperature effect (MMTE) in association with bacterial infection were identified. When used as exogenous supplements, two of the MMTE, i.e., L-methionine and UDP-glucose, effectively upregulated the expression of pro-inflammatory cytokines and suppressed E. tarda infection in flounder leukocytes. Taken together, the results of this study indicate an important influence of temperature on the metabolism of flounder during bacterial infection, which eventually affects the survivability of the fish.Entities:
Keywords: Edwardsiella; Paralichthys olivaceus; bacterial infection; biomarker; edwardsiellosis; global warming; metabolism; temperature
Mesh:
Substances:
Year: 2022 PMID: 36189244 PMCID: PMC9520329 DOI: 10.3389/fimmu.2022.1010948
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
Primers used for qRT-PCR.
| Gene name | Forward primer(5′-3′) | Reverse primer(5′-3′) |
|---|---|---|
| TNF-α | CTGGTGTGGAAGAACGACGA | CGTGAGGTGTTTTTCCGCTG |
| IL-1β | GTCCACCTATGTGCACCCTT | CATTTGTTCTCGACACGCTCC |
| IL-6 | CTCCAGTCGAATACGAGCCC | ACTCTTTCTGGTGGTGAGCG |
| IL-8 | GCCTGAGAAGCCTAGGAGTG | TGACTCTCTTCACCCACGGA |
| IL-27β | TGGCTGCGATGTTGGTTACT | TTCAGGCCAGGAGCAAAGAG |
| β-actin | GCACGGTATTGTGACCAACTGG | CAGGGGAGCCTCTGTGAGC |
Figure 1OPLS-DA score plots. The OPLS-DA score plots of LI−LC (A, B), HI−HC (C, D), HC−LC (E, F) and HI−LI (G, H) were obtained in negative (A, C, E, G) and positive ionization modes (B, D, F, H).
Figure 2Heatmap representation of the SDMs in LI−LC and HI−HC. The relative metabolite abundance in LC−LI (A) and HC−HI (B) are shown. Red and blue represent up- and down-regulation, respectively. ★, metabolites occurring in both LI−LC and HI−HC.
Figure 3Heatmap representation of the SDMs in HC−LC and HI−LI. The relative metabolite abundance in HC−LC (A) and HI−LI (B) are shown. Red and blue represent up- and down-regulation, respectively. ★, metabolites occurring in both HC−LC and HI−LI.
List of the 57 SDMs in HI−LI. "+" and "-" indicate up- and down-regulations, respectively, at high temperature compared to low temperature.
| Metabolites | VIP | Fold change |
| m/z | rt(s) |
|---|---|---|---|---|---|
| L-Anserine | 3.68 | +5.69 | 1.61E-06 | 241.13 | 819.70 |
| Dimethyl sulfone | 3.13 | +5.12 | 5.81E-07 | 226.98 | 725.40 |
| alpha-D-Galactose 1-phosphate | 1.08 | +4.27 | 1.25E-02 | 241.01 | 720.80 |
| Protocatechuic acid | 1.89 | +3.41 | 8.34E-08 | 153.02 | 689.08 |
| D-Pinitol | 1.06 | +3.16 | 2.07E-03 | 261.03 | 944.86 |
| DL-2-Aminoadipic acid | 1.37 | +3.12 | 6.83E-05 | 144.06 | 798.12 |
| L-Saccharopine | 1.12 | +2.77 | 3.02E-05 | 275.12 | 819.47 |
| Glycerol 3-phosphate | 1.37 | +2.72 | 1.35E-04 | 171.01 | 777.84 |
| Glutaric acid | 8.04 | +2.39 | 1.23E-07 | 131.03 | 689.12 |
| Isobutyric acid | 2.47 | +2.29 | 1.62E-06 | 87.04 | 689.13 |
| N-Acetylglucosamine 1-phosphate | 1.15 | +2.29 | 2.72E-06 | 300.05 | 797.92 |
| 2-Oxoadipic acid | 11.49 | +2.14 | 5.06E-08 | 141.02 | 666.69 |
| D-Ribose 5-phosphate | 2.51 | -2.02 | 3.03E-04 | 289.03 | 836.59 |
| sn-Glycerol 3-phosphoethanolamine | 1.18 | -2.03 | 4.04E-02 | 216.06 | 778.73 |
| N-Acetyl-L-alanine | 2.01 | -2.04 | 1.27E-04 | 130.05 | 446.69 |
| DL-Serine | 3.94 | -2.05 | 1.05E-04 | 104.03 | 678.82 |
| Pro-Asp | 3.91 | -2.07 | 2.09E-04 | 291.12 | 914.23 |
| Thioetheramide-PC | 5.74 | -2.16 | 1.90E-02 | 758.58 | 142.21 |
| ketoisocaproic acid | 2.82 | -2.16 | 1.85E-02 | 129.05 | 222.04 |
| Phosphorylcholine | 1.42 | -2.17 | 7.35E-05 | 242.08 | 711.53 |
| L-Aspartate | 6.01 | -2.18 | 2.77E-03 | 132.03 | 725.44 |
| Lys-Ser | 1.72 | -2.24 | 1.54E-04 | 275.17 | 907.40 |
| SOPC | 1.36 | -2.29 | 1.82E-05 | 787.61 | 308.38 |
| Succinate | 3.02 | -2.30 | 9.14E-05 | 136.06 | 598.66 |
| L-Threonine | 5.11 | -2.30 | 2.44E-04 | 118.05 | 635.86 |
| 2-Methoxybenzoic acid | 2.18 | -2.35 | 2.97E-03 | 152.05 | 522.31 |
| D-Ornithine | 2.03 | -2.38 | 7.78E-04 | 131.08 | 968.69 |
| L-Valine | 5.66 | -2.40 | 2.05E-06 | 118.08 | 597.20 |
| UDP-Glucose | 1.22 | -2.40 | 3.71E-03 | 565.05 | 801.17 |
| Pro-Gln | 2.47 | -2.43 | 1.82E-03 | 304.15 | 886.65 |
| Argininosuccinic acid | 2.36 | -2.44 | 1.50E-05 | 289.11 | 854.80 |
| trans-cinnamate | 2.32 | -2.44 | 5.54E-04 | 147.04 | 456.64 |
| 6-Phospho-D-gluconate | 1.18 | -2.44 | 6.99E-04 | 275.02 | 886.42 |
| Guanosine | 1.84 | -2.46 | 1.24E-02 | 282.08 | 480.56 |
| N-Acetyl-D-lactosamine | 1.33 | -2.47 | 1.64E-03 | 404.12 | 661.05 |
| L-Leucine | 16.75 | -2.47 | 5.16E-04 | 130.09 | 466.98 |
| N6-Methyl-L-lysine | 1.58 | -2.48 | 8.31E-04 | 161.13 | 1070.15 |
| N6-Acetyl-L-lysine | 3.62 | -2.49 | 5.18E-06 | 187.11 | 636.67 |
| L-Tyrosine | 7.30 | -2.53 | 5.91E-04 | 180.07 | 538.85 |
| L-Arginine | 4.47 | -2.55 | 1.73E-03 | 173.10 | 966.58 |
| L-Phenylalanine | 9.55 | -2.66 | 1.44E-03 | 166.08 | 514.27 |
| Tyramine | 7.51 | -2.67 | 9.72E-04 | 120.08 | 514.45 |
| Alpha-D-Glucose | 1.40 | -2.71 | 5.03E-06 | 179.06 | 467.09 |
| Adenosine 3’-monophosphate | 1.87 | -2.77 | 1.53E-02 | 346.05 | 731.88 |
| D-4-Hydroxyphenylglycine | 1.30 | -2.85 | 1.13E-04 | 168.07 | 753.34 |
| L-Tryptophan | 3.53 | -2.89 | 4.20E-03 | 203.08 | 458.97 |
| L-Threonate | 2.33 | -2.90 | 1.59E-02 | 135.03 | 554.94 |
| DL-Methionine sulfoxide | 4.41 | -2.93 | 4.19E-04 | 164.04 | 662.89 |
| L-Methionine | 4.28 | -3.06 | 3.67E-03 | 148.04 | 506.72 |
| Guanosine 5’-monophosphate (GMP) | 1.32 | -3.09 | 4.44E-02 | 362.05 | 794.25 |
| 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine | 3.13 | -3.10 | 4.20E-02 | 786.61 | 138.88 |
| Arg-Phe | 1.40 | -3.17 | 3.80E-04 | 286.17 | 602.04 |
| L-Pipecolic acid | 6.35 | -3.19 | 3.11E-05 | 130.08 | 1042.18 |
| Ribitol | 1.04 | -3.57 | 1.33E-05 | 151.06 | 409.91 |
| D-gluconate | 4.47 | -3.66 | 9.93E-04 | 195.05 | 665.90 |
| L-Lysine | 7.40 | -4.47 | 6.44E-05 | 145.10 | 984.57 |
| Pro-Gly | 1.16 | -5.47 | 1.08E-04 | 345.17 | 698.36 |
Figure 4KEGG enrichment (top 10) of the unique SDMs in HI−LI. The p-value was set as < 0.05.
Top 10 KEGG enriched pathways of the unique SDMs in HI−LI. The p-value was set as < 0.05. Up and down arrows indicate up- and down-regulations, respectively.
| Metabolic pathway | Hits |
| Metabolites |
|---|---|---|---|
| Aminoacyl-tRNA biosynthesis | 10 | 8.77E-07 | L-Valine (↓), L-Phenylalanine (↓), |
| Valine, leucine and isoleucine biosynthesis | 4 | 5.37E-05 | L-Threonine (↓), L-Leucine (↓), L-Valine (↓), Ketoisocaproic acid (↓) |
| Lysine degradation | 5 | 8.00E-04 | L-Lysine (↓), L-Saccharopine (↓), DL-2-Aminoadipic acid (↑), 2-Oxoadipic acid (↑), L-Pipecolic acid (↓) |
| Phenylalanine, tyrosine and tryptophan biosynthesis | 2 | 5.53E-03 | L-Phenylalanine (↓), L-Tyrosine (↓) |
| Arginine biosynthesis | 3 | 8.21E-03 | L-Arginine (↓), L-Aspartate (↓), Argininosuccinic acid (↓) |
| Phenylalanine metabolism | 2 | 2.38E-02 | L-Phenylalanine (↓), L-Tyrosine (↓) |
| Glycerophospholipid metabolism | 4 | 2.85E-02 | Phosphorylcholine (↓), Choline phosphate (↓), Glycerol 3-phosphate (↑), sn-Glycerol 3-phosphoethanolamine (↓) |
| Pentose phosphate pathway | 3 | 2.91E-02 | D-Ribose 5-phosphate (↓), 6-Phospho-D-gluconate (↓), D-gluconate (↓) |
| Galactose metabolism | 3 | 4.97E-02 | Alpha-D-Glucose (↓), UDP-glucose (↓), alpha-D-Galactose 1-phosphate (↑) |
| Alanine, aspartate and glutamate metabolism | 3 | 4.97E-02 | L-Aspartate (↓), Argininosuccinic acid (↓), Succinate (↓) |
Figure 5Venn diagrams showing the intersection between the SDMs in LI−LC and HI−LI (A) and the SDMs in HI−HC and HI−LI (B). The blue circles represent LI−LC (A) and HI−HC (B). The pink circles represent HI−LI.
List of the 22 SDMs shared between LI−LC and HI−LI. "+" and "-" indicate up- and down-regulations, respectively.
| Metabolites | LI−LC | HI−LI | ||||
|---|---|---|---|---|---|---|
| VIP | Fold change |
| VIP | Fold change |
| |
| DL-2-Aminoadipic acid | 1.19 | +5.70 | 4.98E-03 | 1.37 | +3.12 | 6.83E-05 |
| L-Methionine | 4.62 | +4.02 | 1.78E-02 | 4.28 | -3.06 | 3.67E-03 |
| L-Tryptophan | 3.91 | +3.07 | 3.54E-03 | 3.53 | -2.89 | 4.20E-03 |
| L-Lysine | 7.27 | +2.93 | 8.73E-04 | 7.40 | -4.47 | 6.44E-05 |
| Alpha-D-Glucose | 1.51 | +2.72 | 3.22E-04 | 1.40 | -2.71 | 5.03E-06 |
| L-Arginine | 4.91 | +2.64 | 1.06E-03 | 4.47 | -2.55 | 1.73E-03 |
| D-Ornithine | 2.29 | +2.59 | 2.62E-04 | 2.03 | -2.38 | 7.78E-04 |
| Pro-Gly | 1.16 | +2.58 | 2.46E-03 | 1.16 | -5.47 | 1.08E-04 |
| Phosphorylcholine | 1.65 | +2.55 | 5.94E-05 | 1.42 | -2.17 | 7.35E-05 |
| L-Aspartate | 6.90 | +2.50 | 1.41E-03 | 6.01 | -2.18 | 2.77E-03 |
| Glycerol 3-phosphate | 1.05 | +2.48 | 1.19E-05 | 1.37 | +2.72 | 1.35E-04 |
| D-gluconate | 4.17 | +2.45 | 1.08E-02 | 4.47 | -3.66 | 9.93E-04 |
| Tyramine | 8.77 | +2.37 | 2.35E-03 | 7.51 | -2.67 | 9.72E-04 |
| L-Tyrosine | 7.65 | +2.37 | 1.01E-03 | 7.30 | -2.53 | 5.91E-04 |
| L-Phenylalanine | 11.28 | +2.35 | 3.46E-03 | 9.55 | -2.66 | 1.44E-03 |
| L-Pipecolic acid | 6.74 | +2.29 | 7.53E-04 | 6.35 | -3.19 | 3.11E-05 |
| Pro-Gln | 2.59 | +2.08 | 7.83E-03 | 2.47 | -2.43 | 1.82E-03 |
| Arg-Phe | 1.44 | +2.06 | 4.10E-03 | 1.40 | -3.17 | 3.80E-04 |
| Glutaric acid | 4.37 | +2.05 | 1.53E-03 | 8.04 | +2.39 | 1.23E-07 |
| Isobutyric acid | 1.39 | +2.02 | 2.64E-03 | 2.47 | +2.29 | 1.62E-06 |
| L-Leucine | 16.12 | +2.01 | 3.46E-03 | 16.75 | -2.47 | 5.16E-04 |
| Guanosine | 3.57 | -2.24 | 2.98E-04 | 1.84 | -2.46 | 1.24E-02 |
List of the 16 SDMs shared between HI−HC and HI−LI. "+" and "-" indicate upregulation and downregulation, respectively.
| Metabolites | HI−HC | HI−LI | ||||
|---|---|---|---|---|---|---|
| VIP | Fold change |
| VIP | Fold change |
| |
| DL-2-Aminoadipic acid | 1.83 | +26.03 | 4.89E-08 | 1.37 | +3.12 | 6.83E-05 |
| L-Anserine | 4.30 | +8.54 | 4.75E-07 | 3.68 | +5.69 | 1.61E-06 |
| Protocatechuic acid | 1.95 | +7.22 | 3.54E-09 | 1.89 | +3.41 | 8.34E-08 |
| Glutaric acid | 8.99 | +6.42 | 6.96E-11 | 8.04 | +2.39 | 1.23E-07 |
| Isobutyric acid | 2.80 | +6.05 | 8.19E-10 | 2.47 | +2.29 | 1.62E-06 |
| L-Saccharopine | 1.17 | +4.16 | 1.70E-06 | 1.12 | +2.77 | 3.02E-05 |
| Dimethyl sulfone | 3.24 | +3.89 | 2.02E-06 | 3.13 | +5.12 | 5.81E-07 |
| 3-Methoxy-4-Hydroxyphenylglycol Sulfate | 3.81 | +2.29 | 9.79E-03 | 4.61 | +3.56 | 6.21E-04 |
| Glycerol 3-phosphate | 1.18 | +2.10 | 7.95E-04 | 1.37 | +2.72 | 1.35E-04 |
| Thioetheramide-PC | 10.43 | -3.15 | 3.13E-03 | 5.74 | -2.16 | 1.90E-02 |
| L-Pipecolic acid | 1.08 | -3.30 | 4.35E-02 | 6.35 | -3.19 | 3.11E-05 |
| 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine | 3.86 | -3.35 | 3.84E-02 | 3.13 | -3.10 | 4.20E-02 |
| SOPC | 2.22 | -3.52 | 3.30E-03 | 1.36 | -2.29 | 1.82E-05 |
| 2-Methoxybenzoic acid | 4.30 | -3.81 | 1.19E-05 | 2.18 | -2.35 | 2.97E-03 |
| UDP-Glucose | 2.14 | -5.15 | 1.94E-06 | 1.22 | -2.40 | 3.71E-03 |
| Guanosine | 1.20 | -7.87 | 3.18E-05 | 1.84 | -2.46 | 1.24E-02 |
Figure 6The effects of selected metabolites on Edwardsiella tarda infection and cytokine expression. (A) Flounder leukocytes were pre-incubated with L-lysine, L-methionine, L-pipecolic acid, or UDP-glucose for 6 h, and then infected with E tarda for 2h Cell-infected bacteria (shown as Colony Forming Unit, CFU) were determined by plate count. (B) The cells treated above were subjected to qRT-PCR to analyze the expression of TNF-α, IL-1β, IL-6, IL-8, and IL-27β. **, p < 0.01. For both panels, values are the means ± SEM of three independent experiments. **, p < 0.01.